Skip to content

Category: News

RPM Report: “Testing a New Model for Personalized Drug Development”

MIT Technology Review: “Genomics Could Blow Up the Clinical Trial”

Wall Street Journal: “Foundation Medicine Partners with Broad-based Coalition to Advance Revolutionary New Clinical Trial Design in Lung Cancer” (Press Release)

Boston Globe: “Foundation Medicine is part of an effort to advance new clinical trial design in lung cancer”

Forbes: “With New Study, Scientists Try to Drag Drug Trials Into DNA Age”

The ASCO Post: “’Master Protocol’ Could Revolutionize Trials in Lung Cancer, Eventually Other Cancers”

Nature: “’Master Protocol’ Aims to Revamp Cancer Trials”

RPM Report: “Landmark Trial for Personalized Medicine Coming Soon: NGS Approval May Be One Offshoot of Lung Cancer ‘Master Protocol’”